$FFR Balance Sheet | Understand Stock

$FFR

$1.11 +$0.04 (3.74%) Close

$FFR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
ASSETS
Current assets
Cash
Accounts receivable, net
Inventory, net
Cash and cash equivalents
Crypto asset fair value
Prepaid investments – related party
Prepaid expenses and other current assets
Current assets of discontinued operations
Short-term note receivable - Marizyme
Short-term notes receivable, net of allowance for credit losses of nil at June 30, 2026 and $4.6 million at December 31, 2025
Other current assets
Total current assets

Restricted cash
Right-of-use assets
Property and equipment, net
Equipment held for lease, net
Intangible assets, net
Goodwill
Non-current assets
Intangible assets
Other assets - related party
Related Party
Nonrelated Party
Total other assets - related party
Non-current assets of discontinued operations
Total non-current assets

Total Assets

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable
Accrued vacation
Related Party Payable
Accrued expenses and other current liabilities
R&D grant liability
Deferred revenue, current portion
Operating lease liability, current portion
Short term debt-related party
Warrant liabilities - related party
Current liabilities of discontinued operations
Warrant liabilities
Convertible debt
Related Party
Nonrelated Party
Total convertible debt
Derivative liabilities
Related Party
Nonrelated Party
Total derivative liabilities
Promissory notes
Total current liabilities

Operating lease liability, net of current portion
Deferred revenue, net of current portion
Deferred tax liability
Non-current liabilities of discontinued operations

Non-current liabilities of discontinued operations
Total liabilities
Stockholders’ Equity
Preferred stock, value
Series A Preferred Stock
Series A-2 Preferred Stock
Series B Preferred Stock
Total preferred stock, value
Common stock, $0.001 par value; 225,000,000 shares authorized; 20,234,993 and 5,160,383 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated other comprehensive income
Parent company equity held at cost
Accumulated deficit
Total Stockholders’ Equity
Noncontrolling interest

Total Liabilities & Stockholders’ Equity

Comments